A landmark study shows that receiving the recombinant shingles vaccine reduces the risk of heart failure, stroke, and coronary disease by curbing systemic inflammation.
A landmark study shows that receiving the recombinant shingles vaccine reduces the risk of heart failure, stroke, and coronary disease by curbing systemic inflammation.
